These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 27178693)
1. Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment. Kim C; Cheng J; Colegio OR Semin Oncol; 2016 Jun; 43(3):390-4. PubMed ID: 27178693 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach. Ritchie SA; Patel MJ; Miller SJ Dermatol Surg; 2012 Oct; 38(10):1604-21. PubMed ID: 22646842 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients. Cheng JY; Li FY; Ko CJ; Colegio OR JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858 [TBL] [Abstract][Full Text] [Related]
4. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs). Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients. Herman S; Rogers HD; Ratner D Skinmed; 2007; 6(5):234-8. PubMed ID: 17786101 [TBL] [Abstract][Full Text] [Related]
6. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Willey A; Mehta S; Lee PK Dermatol Surg; 2010 May; 36(5):652-8. PubMed ID: 19889154 [TBL] [Abstract][Full Text] [Related]
7. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. O'Reilly Zwald F; Brown M J Am Acad Dermatol; 2011 Aug; 65(2):263-279. PubMed ID: 21763562 [TBL] [Abstract][Full Text] [Related]
8. Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients. Endrizzi B; Ahmed RL; Ray T; Dudek A; Lee P Dermatol Surg; 2013 Apr; 39(4):634-45. PubMed ID: 23379978 [TBL] [Abstract][Full Text] [Related]
9. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Harwood CA; Leedham-Green M; Leigh IM; Proby CM Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863 [TBL] [Abstract][Full Text] [Related]
10. The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients. Leblanc KG; Hughes MP; Sheehan DJ Dermatol Surg; 2011 Jun; 37(6):744-9. PubMed ID: 21605234 [TBL] [Abstract][Full Text] [Related]
11. Comment on "Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)". Longo MI; Wen X; Womer KL J Am Acad Dermatol; 2016 May; 74(5):e105-6. PubMed ID: 27085243 [No Abstract] [Full Text] [Related]
12. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors. Que SKT; Zwald FO; Schmults CD J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705 [TBL] [Abstract][Full Text] [Related]
13. Overview on non-melanoma skin cancers in solid organ transplant recipients. Forchetti G; Suppa M; Del Marmol V G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review. Schauder DM; Kim J; Nijhawan RI JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538 [TBL] [Abstract][Full Text] [Related]
15. Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature. Herold M; Good AJ; Nielson CB; Longo MI Dermatol Surg; 2019 Dec; 45(12):1442-1449. PubMed ID: 31403546 [TBL] [Abstract][Full Text] [Related]
16. Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients. Gluck M; Hodak E; Davidovici B Dermatol Ther; 2022 Aug; 35(8):e15649. PubMed ID: 35716099 [TBL] [Abstract][Full Text] [Related]
17. Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients. Bangash HK; Colegio OR Curr Treat Options Oncol; 2012 Sep; 13(3):354-76. PubMed ID: 22592596 [TBL] [Abstract][Full Text] [Related]
18. Skin and gut microbial associations with squamous cell carcinoma in solid organ transplant recipients. Ha MV; McCormick TS; Salem I; Al-Shakhshir H; Ghannoum MA; Carroll BT Arch Dermatol Res; 2023 Nov; 315(9):2709-2713. PubMed ID: 37278910 [TBL] [Abstract][Full Text] [Related]
19. Sequential Curettage, 5-Fluorouracil, and Photodynamic Therapy for Field Cancerization of the Scalp and Face in Solid Organ Transplant Recipients. Jambusaria-Pahlajani A; Ortman S; Schmults CD; Liang C Dermatol Surg; 2016 Jan; 42 Suppl 1():S66-72. PubMed ID: 26730976 [TBL] [Abstract][Full Text] [Related]